Author: kelsey

Home / Articles posted by kelsey

BERLIN, Germany, April 3rd, 2020 – AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) is pleased to announce that it has successfully increased the loan amount it can borrow on its drawn down loan facility announced on December 3rd, 2018 from €500,000 to €1,000000 to finance trade receivables from the import of medical cannabis from the Netherlands in the coming weeks.  The amended drawdown facility will mature December 31, 2021, and borrowed amounts can be repaid...

BERLIN, Germany, January 15th, 2020 – AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) provides an update on its strategy to become one of the leading importers of European Union - Good Manufacturing Practices (EU-GMP) medical cannabis into Germany through its network of suppliers from Canada, Europe and other non-European countries.   2019 Highlights Share floatation on the Canadian Securities and Frankfurt Stock Exchanges, Secured C$750,000 (€500,000) revolving drawdown loan facility, Raised C$1.5-million (€1,035,000) in Series A...

BERLIN, Germany, January 8, 2020 – AMP German Cannabis Group Inc. (“AMP” or the “Company”) (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) announces a non-brokered placement of up to 8,000,000 common shares of the Company at a price of $0.25 per share for gross proceeds of up to $2,000,000. The Company intends to use the net proceeds from the offering to fund its import business, general corporate purposes and working capital. All securities issued pursuant to the offering will be subject to a...

Berlin and Erfurt, Germany - November 18, 2019 –– AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces the Thuringian State Office for Consumer Protection (Thueringer Landesamt fuer Verbraucherschutz) (“TLV”) has granted an import licence for cannabis products for medical purposes for Germany according to Section 72 of the German Medicine Law (Arzneimittelgesetz - AMG) to Alternative Medical Products GmbH (“AMP Germany”), a wholly-owned subsidiary of AMP.   The TLV deals with fundamental matters of economic consumer protection and...

BERLIN, Germany, September 4, 2019 – AMP German Cannabis Group Inc. ("AMP" or the "Company") (formerly "Chinook Tyee Industry Limited") (CSE: XCX), (FSE: C4T), (ISIN: CA00176G1028) announces the commencement of trading of its common shares on the Canadian Securities Exchange (CSE).  The Company's common shares were delisted from the TSX Venture Exchange at the close of market on September 3, 2019. The Company also announces that it has updated investment policy to enhance shareholder value from investments in the European medical...